Better health is associated with a higher risk of heart disease.

Published Date: 17 Feb 2023

UK: More health is associated with more cardiovascular disease (CVD) and higher triglycerides...

Read Full News

Latest News

BEACON: Positive Results Announced for Briquilimab in Chronic Spontaneous Urticaria

BEACON: Positive Results Announced for Briquilimab in Chronic Spontaneous Urticaria

Family Quality of Life Burden in CSU Increased by Lack of Disease Control

Family Quality of Life Burden in CSU Increased by Lack of Disease Control

Upadacitinib Superior to 4 Other JAKi Monotherapies for Atopic Dermatitis

Upadacitinib Superior to 4 Other JAKi Monotherapies for Atopic Dermatitis

Q4 2025 Recap: Dermatology News and Updates

Q4 2025 Recap: Dermatology News and Updates

Racial Disparities in Persistent Chemotherapy-Induced Alopecia Observed in Women

Racial Disparities in Persistent Chemotherapy-Induced Alopecia Observed in Women

6 Dermatology Headlines You Missed in December 2025

6 Dermatology Headlines You Missed in December 2025

Todays Updates

Combination Navepegritide, Lonapegsomatropin Shows Durable Benefit in Phase 2 Pediatric Achondroplasia Trial

Combination Navepegritide, Lonapegsomatropin Shows Durable Benefit in Phase 2 Pediatric Achondroplasia Trial

Todays Updates

Combination Navepegritide, Lonapegsomatropin Shows Durable Benefit in Phase 2 Pediatric Achondroplasia Trial

Combination Navepegritide, Lonapegsomatropin Shows Durable Benefit in Phase 2 Pediatric Achondroplasia Trial

Latest News

BEACON: Positive Results Announced for Briquilimab in Chronic Spontaneous Urticaria

Family Quality of Life Burden in CSU Increased by Lack of Disease Control

Upadacitinib Superior to 4 Other JAKi Monotherapies for Atopic Dermatitis

Q4 2025 Recap: Dermatology News and Updates

Racial Disparities in Persistent Chemotherapy-Induced Alopecia Observed in Women

6 Dermatology Headlines You Missed in December 2025

News All Time

Nemolizumab Rapidly Relieves Itch in Atopic Dermatitis, Prurigo Nodularis

Nemolizumab Rapidly Relieves Itch in Atopic Dermatitis, Prurigo Nodularis

Phase 3 SCALP Study on Clascoterone for Androgenetic Alopecia, With Maria Hordinsky, MD

Phase 3 SCALP Study on Clascoterone for Androgenetic Alopecia, With Maria Hordinsky, MD

Vixarelimab Demonstrates Rapid, Sustained Clinical Benefits in Prurigo Nodularis

Vixarelimab Demonstrates Rapid, Sustained Clinical Benefits in Prurigo Nodularis

Once-Daily Oral Zasocitinib Delivers Strong Phase 3 Efficacy in Plaque Psoriasis

Once-Daily Oral Zasocitinib Delivers Strong Phase 3 Efficacy in Plaque Psoriasis

REZOLVE-AA: Phase 2b Data Released on Rezpegaldesleukin for Alopecia Areata

REZOLVE-AA: Phase 2b Data Released on Rezpegaldesleukin for Alopecia Areata

Special Report: Reframing Skin Pain in Atopic Dermatitis Mona Shahriari, MD, FAAD, Andrew Mastro, MS, PA-C

This video explores skin pain as a key symptom of atopic dermatitis and reviews clinical trial data with JAK inhibitors.

Skin of Color Savvy: Winter Skin Care for Patients of Color, With Heather Woolery-Lloyd, MD, and Aderonke Obayomi, MD, MPH

Skin of Color Savvy: Winter Skin Care for Patients of Color, With Heather Woolery-Lloyd, MD, and Aderonke Obayomi, MD, MPH

Addictive Behaviors Linked with Chronic Skin Diseases Such as HS, Psoriasis

Addictive Behaviors Linked with Chronic Skin Diseases Such as HS, Psoriasis

Prurigo Nodularis Linked to Increased Risk of Malignancy, Especially Skin Cancers

Prurigo Nodularis Linked to Increased Risk of Malignancy, Especially Skin Cancers

Imsidolimab’s Biologics License Application for Treatment of GPP Submitted to FDA

Imsidolimab’s Biologics License Application for Treatment of GPP Submitted to FDA

Dupilumab Shows Greatest Rate of 2-Year Drug Survival Among Atopic Dermatitis Drugs

Dupilumab Shows Greatest Rate of 2-Year Drug Survival Among Atopic Dermatitis Drugs

Tips on Patient Communication in Dermatology, With Kassandra Holzem, MD Kassandra Holzem, MD

Holzem spoke in this interview about several additional highlights from her session at SDPA Fall regarding red flags in dermatology and when to admit from the clinic.

Key Skin Cancer Terms Not Understood by Almost 1/3 of Patients Surveyed

Key Skin Cancer Terms Not Understood by Almost 1/3 of Patients Surveyed

FDA Proposes Expanding Active Ingredient List for Sunscreens

FDA Proposes Expanding Active Ingredient List for Sunscreens

Apremilast Effective Treatment for Moderate to Severe Genital Psoriasis at 32 Weeks

Apremilast Effective Treatment for Moderate to Severe Genital Psoriasis at 32 Weeks

Mild to Moderate Psoriasis Linked with Indicators of Suboptimal Treatment, Disease Control

Mild to Moderate Psoriasis Linked with Indicators of Suboptimal Treatment, Disease Control

Recommended News For You

Modified personalized cancer vaccine generates powerful immune response

Researchers discover that children who survive cancer have socioeconomic challenges.

One CAR T-Cell Therapy for Multiple Myeloma Tops Another in Propensity Matched Study

MCh in Surgical Oncology: Admission, Medical School, Fees, Qualifications Information

WHO releases new R&D landscape analyses highlighting gaps and inequities in cancer research

AI catches one-third of interval breast cancers missed at screening

Cancer care crowdfunding increasingly common, but rarely successful

Recommended Articles For You

Understanding Blood Dyscrasia: Symptoms, Causes and Treatment Options 

The Role of Alanine Aminotransferase in Liver Health and Disease  

Unraveling the Mysteries of Hematocrit: How It Impacts Your Health 

Artificial Intelligence in Oncology: Current Trends, Challenges and Future Outlook 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Immunotherapy Combo Active in Advanced PD-L1-Negative HNSCC

2.

Should the UK introduce targeted prostate cancer screening? The case for and against

3.

Mobile prostate cancer screening clinic can ID the disease in disadvantaged men

4.

Study Supports Lactated Ringer Solution for Fluid Resuscitation in SCD

5.

Highly Successful Treatment of Lynch Syndrome Patients with PD-1 Inhibitors for Colorectal Cancer.

1.

A New Perspective on Spherocytosis: Uncovering Innovative Treatments

2.

AI on the Front Lines: Revolutionizing Breast Cancer Detection with Artificial Intelligence

3.

Breaking Down the Different Types of Lymphoma: What You Need to Know 

4.

Uncovering the Hidden Signs: How to Recognize the Early Symptoms of Colon Cancer

5.

Unlocking the Mystery of Basilar Artery Stroke: A New Approach to Treatment

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Current Scenario of Blood Cancer- Genomic Testing & Advancement in Diagnosis and Treatment

2.

Deep Dive Into EGFR Mutation Positive Non-Small Cell Lung Cancer

3.

Navigating the Complexities of Ph Negative ALL - Part I

4.

Treatment Paradigm for Patients with R/R Adult B-cell ALL- Expert Discussions

5.

Navigating the Complexities of Ph Negative ALL - Part VII

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot